A recent study entitled Elevation of glutathione as a therapeutic strategy in Alzheimers disease concludes: Increasing glutathione remains a promising therapeutic strategy to slow or prevent MCI and Alzheimers disease. Considering that glutathione levels continue to decline as we age, and that both AD and MCI increase with age, supplementation with effective glutathione can play an important role in prevention, or slowing the progression of this disease
Hill AS, et al
GSH also detoxifies electrophilic xenobiotics compounds (chemical carcinogens, environmental pollutants, drugs, etc.) and their metabolites to GSH adduct (GS-X) in the direct catalysis of glutathione-S-transferase (GST, primary approach) [32]
By conferring resistance to a number of chemotherapeutic drugs, an important 2004 study published in the Cell Biochemistry and Function highlights, Elevated levels of glutathione in tumor cells are able to protect such cells in bone marrow, breast, colon, larynx and lung cancers. The reverse is also true
The peptide exhibits anti-inflammatory properties by modulating cytokine production, reducing excessive inflammatory mediators like TNF- and IL-6 while supporting resolution of inflammation and transition to tissue repair phases
Hemmings HC, Egan TD, eds
